SkyePharma has appointed a new senior management team. Frank Condella has been named chief executive and Dr. Ken Cunningham has the newly created position of chief operating officer. Dr. Cunningham’s role will focus on ensuring the effective development of the company’s key products such as Flutiform. Mr. Condella was previously president of the European operations of IVAX prior to its acquisition by Teva in 2005. He was closely involved with the respiratory franchise, one of it...